Therapeutic Payload and Delivery Solutions

Optimized payloads for enhanced efficacy and safety

Revvity empowers gene therapy development with precise therapeutic payload delivery solutions. Whether you’re optimizing CRISPR edits, refining payloads for base editing, or scaling CAR-T programs, our technologies - spanning AAV, lentivirus, and non-viral vectors—help ensure accurate, efficient delivery where it matters most.

Explore the cutting edge of gene editing, where we employ sophisticated delivery methods such as adeno-associated viruses (AAV), lentiviruses (LV), and innovative techniques like our Pin-point™ base editing platform to precisely target and correct disease-causing genes.

Enhance lentiviral transduction efficiency with LentiBOOST™ Technology, a highly effective, non-cytotoxic transduction enhancer that improves lentivirus transduction efficiency by up to 90%, even at lower MOI. Our rigorous practices focus on enhancing the safety and efficacy of these vectors, addressing complex challenges in in vivo gene therapy, from overcoming immune responses to ensuring accurate delivery through approaches like CAR-T.

Unlock the potential of Pin-point base editing platform for precise and safe therapeutic payload development.
Choose the best delivery system from our viral vector and non-viral delivery platforms, optimized for safety and efficacy.
Maximize lentiviral transduction efficiency with LentiBOOST Technology - enhancing delivery across a wide range of cell types.
Enhance your CAR-T therapy development with our specialized tools for cell activation, expansion, and lentivirus-based constructs.

For Research Use Only. Not for use in diagnostic procedures.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

Explore our solutions

Therapeutic payload Delivery CAR-T cell therapy solutions

Therapeutic payload

Achieve high precision, efficiency, and safety in therapeutic payload development with our transformative Pin-point base editing platform. Known for its ability to enhance cell viability and survival, this platform empowers researchers to perform robust target validation, protein functional analysis, drug-gene interaction studies, and optimize therapeutic.

pin-point base editing platform thumbnail

Pin-point™ 塩基編集プラットフォーム

革新的なPin-point塩基編集サービスにより、複数遺伝子の精密かつ効率的な編集を通じて、治療研究を前進させましょう。

Learn more

Delivery

Effective delivery strategies are essential for successful payload targeting and optimal therapeutic outcomes. Our delivery systems offer custom-designed and optimized platforms, featuring viral vectors such as adeno-associated viruses (AAV) and lentiviruses (LV). To further enhance cellular uptake, we provide innovative reagents like LentiBOOST technology, which significantly improves lentiviral transduction efficiency by up to 90%. Our solutions focus on maximizing delivery efficacy and safety while minimizing potential immune responses, ensuring seamless and reliable therapeutic delivery.

Pin-point™ 塩基編集プラットフォーム

革新的なPin-point塩基編集サービスにより、複数遺伝子の精密かつ効率的な編集を通じて、治療研究を前進させましょう。

Learn more

Viral Vector Products

Viral vectors are the most efficient vehicles for gene delivery into a specific cell type or tissue for a wide array of research purposes.

Learn more

LentiBOOST Transduction Enhancer

LentiBOOST^™ technology is a highly effective, non-cytotoxic transduction enhancer for clinical application of lentiviral vectors in a wide range of cell types.

Learn more

Viral-vector-manufacture-services512x288

Viral Vector Engineering and Manufacture

Individualized and customized solutions tailored to fit viral vector projects at all stages of discovery and development, ensuring fast and cost-effective product manufacture.

Learn more

CAR-T cell therapy solutions

The development of CAR-T cells involves genetically modifying T cells to precisely recognize and eliminate cancer cells. From the creation of lentivirus-based constructs to the optimization of cell activation and expansion protocols, we provide a comprehensive suite of platforms and reagents designed to support each critical step in CAR-T therapy development.

MojoSort BioLegend's Magnetic Cell Separation System

Enhance your cell isolation workflow with MojoSort™ magnetic separation. Discover customizable solutions and a wide range of reagents to purify your cells with precision.

Learn more

Cell Counting & Image Cytometry Instruments

Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables. Together, they provide fast, accurate and efficient ways to assess cell health and viability.

Learn more